Form 8-K - Current report:
SEC Accession No. 0001104659-24-130017
Filing Date
2024-12-19
Accepted
2024-12-19 09:00:25
Documents
13
Period of Report
2024-12-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431545d1_8k.htm   iXBRL 8-K 29190
  Complete submission text file 0001104659-24-130017.txt   202323

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20241219.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20241219_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20241219_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2431545d1_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 241561098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)